Copyright Reports & Markets. All rights reserved.

Global Mycoplasma Testing in Clinical Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Mycoplasma Testing in Clinical Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 PCR
      • 1.4.3 ELSA
      • 1.4.4 Enzymatic Methods
      • 1.4.5 DNA Staining
    • 1.5 Market by Application
      • 1.5.1 Global Mycoplasma Testing in Clinical Market Share by Application (2019-2025)
      • 1.5.2 Cell Line Testing
      • 1.5.3 Virus Testing
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Mycoplasma Testing in Clinical Market Size
    • 2.2 Mycoplasma Testing in Clinical Growth Trends by Regions
      • 2.2.1 Mycoplasma Testing in Clinical Market Size by Regions (2019-2025)
      • 2.2.2 Mycoplasma Testing in Clinical Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Mycoplasma Testing in Clinical Market Size by by Players
      • 3.1.1 Global Mycoplasma Testing in Clinical Revenue by by Players (2014-2019)
      • 3.1.2 Global Mycoplasma Testing in Clinical Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Mycoplasma Testing in Clinical Market Concentration Ratio (CR5 and HHI)
    • 3.2 Mycoplasma Testing in Clinical Key Players Head office and Area Served
    • 3.3 Key Players Mycoplasma Testing in Clinical Product/Solution/Service
    • 3.4 Date of Enter into Mycoplasma Testing in Clinical Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Mycoplasma Testing in Clinical Market Size by Type (2014-2019)
    • 4.2 Global Mycoplasma Testing in Clinical Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Mycoplasma Testing in Clinical Market Size (2014-2019)
    • 5.2 Mycoplasma Testing in Clinical Key Players in North America
    • 5.3 North America Mycoplasma Testing in Clinical Market Size by Type
    • 5.4 North America Mycoplasma Testing in Clinical Market Size by Application

    6 Europe

    • 6.1 Europe Mycoplasma Testing in Clinical Market Size (2014-2019)
    • 6.2 Mycoplasma Testing in Clinical Key Players in Europe
    • 6.3 Europe Mycoplasma Testing in Clinical Market Size by Type
    • 6.4 Europe Mycoplasma Testing in Clinical Market Size by Application

    7 China

    • 7.1 China Mycoplasma Testing in Clinical Market Size (2014-2019)
    • 7.2 Mycoplasma Testing in Clinical Key Players in China
    • 7.3 China Mycoplasma Testing in Clinical Market Size by Type
    • 7.4 China Mycoplasma Testing in Clinical Market Size by Application

    8 Japan

    • 8.1 Japan Mycoplasma Testing in Clinical Market Size (2014-2019)
    • 8.2 Mycoplasma Testing in Clinical Key Players in Japan
    • 8.3 Japan Mycoplasma Testing in Clinical Market Size by Type
    • 8.4 Japan Mycoplasma Testing in Clinical Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Mycoplasma Testing in Clinical Market Size (2014-2019)
    • 9.2 Mycoplasma Testing in Clinical Key Players in Southeast Asia
    • 9.3 Southeast Asia Mycoplasma Testing in Clinical Market Size by Type
    • 9.4 Southeast Asia Mycoplasma Testing in Clinical Market Size by Application

    10 India

    • 10.1 India Mycoplasma Testing in Clinical Market Size (2014-2019)
    • 10.2 Mycoplasma Testing in Clinical Key Players in India
    • 10.3 India Mycoplasma Testing in Clinical Market Size by Type
    • 10.4 India Mycoplasma Testing in Clinical Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Mycoplasma Testing in Clinical Market Size (2014-2019)
    • 11.2 Mycoplasma Testing in Clinical Key Players in Central & South America
    • 11.3 Central & South America Mycoplasma Testing in Clinical Market Size by Type
    • 11.4 Central & South America Mycoplasma Testing in Clinical Market Size by Application

    12 International Players Profiles

    • 12.1 Sartorius AG
      • 12.1.1 Sartorius AG Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Mycoplasma Testing in Clinical Introduction
      • 12.1.4 Sartorius AG Revenue in Mycoplasma Testing in Clinical Business (2014-2019))
      • 12.1.5 Sartorius AG Recent Development
    • 12.2 MERCK KGAA
      • 12.2.1 MERCK KGAA Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Mycoplasma Testing in Clinical Introduction
      • 12.2.4 MERCK KGAA Revenue in Mycoplasma Testing in Clinical Business (2014-2019)
      • 12.2.5 MERCK KGAA Recent Development
    • 12.3 ELITechGROUP
      • 12.3.1 ELITechGROUP Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Mycoplasma Testing in Clinical Introduction
      • 12.3.4 ELITechGROUP Revenue in Mycoplasma Testing in Clinical Business (2014-2019)
      • 12.3.5 ELITechGROUP Recent Development
    • 12.4 Bio-Rad Laboratories, Inc.
      • 12.4.1 Bio-Rad Laboratories, Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Mycoplasma Testing in Clinical Introduction
      • 12.4.4 Bio-Rad Laboratories, Inc. Revenue in Mycoplasma Testing in Clinical Business (2014-2019)
      • 12.4.5 Bio-Rad Laboratories, Inc. Recent Development
    • 12.5 Eurofins Scientific
      • 12.5.1 Eurofins Scientific Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Mycoplasma Testing in Clinical Introduction
      • 12.5.4 Eurofins Scientific Revenue in Mycoplasma Testing in Clinical Business (2014-2019)
      • 12.5.5 Eurofins Scientific Recent Development
    • 12.6 Minerva Biolabs
      • 12.6.1 Minerva Biolabs Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Mycoplasma Testing in Clinical Introduction
      • 12.6.4 Minerva Biolabs Revenue in Mycoplasma Testing in Clinical Business (2014-2019)
      • 12.6.5 Minerva Biolabs Recent Development
    • 12.7 Charles River
      • 12.7.1 Charles River Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Mycoplasma Testing in Clinical Introduction
      • 12.7.4 Charles River Revenue in Mycoplasma Testing in Clinical Business (2014-2019)
      • 12.7.5 Charles River Recent Development
    • 12.8 Clongen Laboratories
      • 12.8.1 Clongen Laboratories Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Mycoplasma Testing in Clinical Introduction
      • 12.8.4 Clongen Laboratories Revenue in Mycoplasma Testing in Clinical Business (2014-2019)
      • 12.8.5 Clongen Laboratories Recent Development
    • 12.9 BioFire Diagnostics
      • 12.9.1 BioFire Diagnostics Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Mycoplasma Testing in Clinical Introduction
      • 12.9.4 BioFire Diagnostics Revenue in Mycoplasma Testing in Clinical Business (2014-2019)
      • 12.9.5 BioFire Diagnostics Recent Development
    • 12.10 PromoCell GmbH
      • 12.10.1 PromoCell GmbH Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Mycoplasma Testing in Clinical Introduction
      • 12.10.4 PromoCell GmbH Revenue in Mycoplasma Testing in Clinical Business (2014-2019)
      • 12.10.5 PromoCell GmbH Recent Development
    • 12.11 Lonza
    • 12.12 Roche
    • 12.13 Agilent Technologies, Inc.
    • 12.14 Liofilchem Srl
    • 12.15 ZEAKON Diagnostics

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report studies the Mycoplasma Testing in Clinical, the only way to confirm mycoplasma contamination is by routine testing using one or more special techniques, including direct growth on broth/agar, specific DNA staining, PCR, ELISA, RNA labeling and enzymatic procedures.
      In 2018, the global Mycoplasma Testing in Clinical market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Mycoplasma Testing in Clinical status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mycoplasma Testing in Clinical development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Sartorius AG
      MERCK KGAA
      ELITechGROUP
      Bio-Rad Laboratories, Inc.
      Eurofins Scientific
      Minerva Biolabs
      Charles River
      Clongen Laboratories
      BioFire Diagnostics
      PromoCell GmbH
      Lonza
      Roche
      Agilent Technologies, Inc.
      Liofilchem Srl
      ZEAKON Diagnostics

      Market segment by Type, the product can be split into
      PCR
      ELSA
      Enzymatic Methods
      DNA Staining

      Market segment by Application, split into
      Cell Line Testing
      Virus Testing
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Mycoplasma Testing in Clinical status, future forecast, growth opportunity, key market and key players.
      To present the Mycoplasma Testing in Clinical development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Mycoplasma Testing in Clinical are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now